Although multiple pathways have reported to be altered in ESCC, including PIK3CA, TP53, KRAS, and epidermal growth factor receptor (EGFR) [4, 5], other molecular mechanisms involved in the initiation, progression, and metastasis of ESCC remain elusive [6–8]. Here, EGFR is linked to esophageal squamous cell carcinoma.